DEFA14A: Bicycle Therapeutics Appoints Felix J. Baker to Board, Enters Registration Rights Agreement with Baker Brothers Funds

Bicycle Therapeutics plc announced the appointment of Felix J. Baker, Ph.D. to its Board of Directors and the execution of a registration rights agreement with Baker Brothers funds, granting them certain resale registration rights.

Summary

• Bicycle Therapeutics plc appointed Felix J. Baker, Ph.D., to its Board of Directors, effective April 18, 2024.
• Dr. Baker fills the vacancy created by the resignation of Veronica Jordan, Ph.D., who stepped down as a Class I director, Chair of the Compensation Committee, and member of the Audit Committee, effective April 17, 2024.
• Dr. Jordan will continue to serve the Company as a consultant under a two-year consulting agreement, receiving GBP 12,000 per year.
• The Board has determined that Dr. Baker is independent pursuant to the rules of the Nasdaq Stock Market LLC.
• Concurrently, Bicycle Therapeutics entered into a registration rights agreement with 667, L.P. and Baker Brothers Life Sciences, L.P. (collectively, the BBA Funds).
• The BBA Funds are entitled to certain resale registration rights with respect to the Company's ordinary shares and American Depositary Shares held by them.
• The Company is obligated to file a resale registration statement on Form S-3 covering the Affiliate Registrable Securities within 60 days of a request by the BBA Funds.
• The BBA Funds also have the right to one underwritten offering per calendar year, but no more than three in total and no more than two underwritten offerings or block trades in any 12-month period.
• The Company will pay certain expenses related to such registrations and indemnify the BBA Funds against certain liabilities.

Sentiment

Score: 7

Explanation: The announcement is neutral to positive. The board change is routine, and the registration rights agreement provides liquidity for a major investor, which can be viewed positively. There are no immediate negative implications.

Positives

• The appointment of Felix J. Baker, Ph.D., brings additional expertise to the Board.
• The Affiliate Registration Rights Agreement provides the BBA Funds with liquidity options for their holdings.
• Continued consulting agreement with Dr. Jordan ensures continued access to her expertise.
• The Board has determined that Dr. Baker is independent pursuant to the rules of the Nasdaq Stock Market LLC.

Negatives

• Resignation of Veronica Jordan, Ph.D., results in the loss of her contributions as a director and committee chair.
• The Affiliate Registration Rights Agreement could potentially lead to increased selling pressure on the Company's stock if the BBA Funds choose to exercise their registration rights.

Risks

• The BBA Funds exercising their registration rights could increase the supply of shares in the market, potentially impacting the stock price.
• The Company's obligation to file a registration statement within 60 days of a request from the BBA Funds could strain resources.
• The Company may be required to indemnify the BBA Funds against certain liabilities, which could impact its financial performance.

Future Outlook

The Company will file a resale registration statement on Form S-3 covering the Affiliate Registrable Securities within 60 days of a request by the BBA Funds and will allow for one underwritten offering per calendar year, but no more than three in total and no more than two underwritten offerings or block trades in any 12-month period.

Industry Context

Registration rights agreements are common in deals with significant investors, providing them with a mechanism to liquidate their holdings. Board changes are a normal part of corporate governance.

Comparison to Industry Standards

• The terms of the registration rights agreement, including the number of underwritten offerings allowed, are generally consistent with industry standards for similar agreements.
• The compensation for the consulting agreement with Veronica Jordan appears reasonable based on her expertise and prior role within the company.
• Baker Brothers' investment and board representation are common in the biotech industry, reflecting their active role in supporting and guiding companies they invest in.

Management Changes

Related Party Transactions

• The consulting agreement with Veronica Jordan is a related party transaction.
• The Affiliate Registration Rights Agreement with the BBA Funds, who hold more than 10% of the Company's outstanding shares, is a related party transaction.

Stakeholder Impact

• Shareholders may be impacted by the potential for increased selling pressure if the BBA Funds exercise their registration rights.
• Employees are unlikely to be directly impacted by these changes.
• Customers and suppliers are unlikely to be directly impacted by these changes.
• Creditors are unlikely to be directly impacted by these changes.

Next Steps

• The Company will file a resale registration statement on Form S-3 if requested by the BBA Funds.
• Dr. Baker will join the NCGC and Scientific Committee of the Board.
• Dr. Jordan will begin her consulting role with the Company.

Key Dates

Keywords

registration rights, board of directors, corporate governance, Baker Brothers, Bicycle Therapeutics, appointment, resignation